C I Pharmaceuticals Pvt. Ltd
About C I Pharmaceuticals Pvt. Ltd
Data last updated:
C I Pharmaceuticals Pvt. Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 August 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24233WB1988PTC045057.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹5.3 Lakh. It is led by directors Indra Chandra Bharech and Raj Kumar Bharech.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 56/1 B R B Basu Road, Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2025, the company reported a revenue of ₹37,816, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1,094 (net margin 2.9%) and EBITDA of ₹1,294 (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
C I Pharmaceuticals Pvt. Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address56/1 B R B Basu Road, Kolkata, West Bengal, India – 700001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of C I Pharmaceuticals Pvt. Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of C I Pharmaceuticals Pvt. Ltd
FY 2025 filings availableC I Pharmaceuticals Pvt. Ltd reported revenue of ₹37,816 (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 3% growth in the latest year. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,294 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,094 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of C I Pharmaceuticals Pvt. Ltd, buy the company report.
Board of directors of C I Pharmaceuticals Pvt. Ltd
C I Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indra Chandra Bharech Also directs: C.I.Laboratories (Shibpore) Private Limited | Director | 29 Aug 1988 | 38 Years 2 Months | Current |
| Raj Kumar Bharech Also directs: Pushpa Shree (India) Ltd, Rishi Chemical Works Pvt Ltd, Kreesent Pharma Pvt Ltd and 5 more | Director | 29 Aug 1988 | 38 Years 2 Months | Current |
Peer comparison
C I Pharmaceuticals Pvt. Ltd is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dasm Pharmaceuticals Private Limited | ₹38,920 (FY 2020) | Kalyan, Maharashtra, India | ||||
| Bluzin Pharmaceuticals Private Limited | ₹38,763 (FY 2022) | -64.0% | Mathura, Uttar Pradesh, India | |||
| Aween Pharmaceuticals Private Limited | ₹38,500 (FY 2019) | Narayanpur, Bihar, India | ||||
| Lyfeed Pharmaceuticals Private Limited | ₹38,492 (FY 2025) | -23.0% | New Delhi, Delhi, India | |||
| Pirincs Pharmaceuticals Private Limited | ₹37,830 (FY 2023) | 5905.0% | Lucknow, Uttar Pradesh, India | |||
| C I Pharmaceuticals Pvt. Ltdthis company | ₹37,816 (FY 2025) | ₹1,094 | 2.9% | 3.0% | Kolkata, West Bengal, India | |
| Mizzle Drugs and Pharmaceuticals Private Limited | ₹37,736 (FY 2018) | -57.0% | Madurai, Tamil Nadu, India | |||
| Tutelage Pharmaceuticals Private Limited | ₹37,500 (FY 2021) | Bareilly, Uttar Pradesh, India | ||||
| Indoerwin Pharmaceuticals Private Limited | ₹37,047 (FY 2021) | Bengaluru, Karnataka, India | ||||
| Liven Pharmaceuticals Private Limited | ₹36,800 (FY 2024) | -55.0% | Bhopal, Madhya Pradesh, India | |||
| M.C.Shroff Pharmaceuticals Limited | ₹36,250 (FY 2025) | 304.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of C I Pharmaceuticals Pvt. Ltd, buy the company report.
Auditor
C I Pharmaceuticals Pvt. Ltd is audited by M.L.CHOUDHRY& CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.L.CHOUDHRY& CO. | FY 2017 | 306125E |
Shareholding
The shareholding of C I Pharmaceuticals Pvt. Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of C I Pharmaceuticals Pvt. Ltd, buy the company report.
Legal cases
C I Pharmaceuticals Pvt. Ltd has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed against the company by M - S Principal Pharmaceuticals | Disposed |
To see the full case history of C I Pharmaceuticals Pvt. Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for C I Pharmaceuticals Pvt. Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for C I Pharmaceuticals Pvt. Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
C I Pharmaceuticals Pvt. Ltd has 3 board changes on record since 1988: 2 appointments and 1 cessation. The latest: Narayan Prakash Bharech ceased to be Director on 10 May 2019.
Frequently asked questions
C I Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 August 1988 (38+ years old) and is registered under CIN U24233WB1988PTC045057.
C I Pharmaceuticals has 2 current directors:
- Indra Chandra Bharech - Director
- Raj Kumar Bharech - Director
The latest financial statements of C I Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of C I Pharmaceuticals is U24233WB1988PTC045057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
C I Pharmaceuticals has 2 court cases on record: 2 filed against it.
C I Pharmaceuticals was incorporated on 29 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of C I Pharmaceuticals by revenue are Dasm Pharmaceuticals Private Limited, Bluzin Pharmaceuticals Private Limited, Aween Pharmaceuticals Private Limited, Lyfeed Pharmaceuticals Private Limited, Pirincs Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Narayan Prakash Bharech ceased to be Director on 10 May 2019. Indra Chandra Bharech was appointed as Director on 29 Aug 1988. Raj Kumar Bharech was appointed as Director on 29 Aug 1988.
The registered office of C I Pharmaceuticals is at 561 B R B Basu Road, Kolkata, West Bengal, India – 700001.
C I Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of C I Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
